Gabriela Schmajuk, MD, MS

Associate Professor

Dr. Schmajuk is Chief of Rheumatology at the San Francisco VA Health Care System and an Associate Professor in the Division of Rheumatology, Department of Medicine at UCSF. She received her undergraduate degree from Harvard, her MD from the University of Pennsylvania, and her Masters in Epidemiology from Stanford. She joined the faculty after completing internal medicine residency at Brigham and Women's Hospital and fellowship in rheumatology at Stanford. She practices in the SFVA rheumatology clinic.

Dr. Schmajuk's research focuses on quality of care and patient safety in patients with rheumatic diseases. She co-directs the UCSF Rheumatology Quality and Informatics Lab (quil.ucsf.edu), an interdisciplinary group that uses health services research, informatics, and implementation science to inform national health care improvement initiatives. Her work specifically highlights and aims to attenuate disparities in care across sex, race/ethnicity, socioeconomic status, and health literacy. She uses a variety of "big data" sources, including Medicare and EHR data from the VA and the he American College of Rheumatology’s RISE registry, which aggregates and analyzes data from rheumatology practices around the country. She also has projects to use Health-IT to integrate patient reported outcomes into clinical encounters in rheumatology.

Dr. Schmajuk has served as PI of grants from the NIH/NIAMS, AHRQ, and VA HSR&D, and has earned several honors and awards for her work, including the Ephraim Engleman Award for Arthritis Research, and the J.V. Satterfield Excellence in Rheumatology Research Award from the Arthritis Foundation.
Education
- Internal Medicine, Brigham and Women's Hospital
AB, - Biochemical Sciences, Harvard University
- Rheumatology, Stanford Hospital
MSc, - Epidemiology, Stanford University
- Diversity, Equity, and Inclusion Champion Training, UCSF
MD, - Medicine, University of Pennsylvania
Websites
Publications

  1. Somebang K, Rudolph J, Imhof I, Li L, Niemi EC, Shigenaga J, Tran H, Gill TM, Lo I, Zabel BA, Schmajuk G, Wipke BT, Gyoneva S, Jandreski L, Craft M, Benedetto G, Plowey ED, Charo I, Campbell J, Ye CJ, Panter SS, Nakamura MC, Eckalbar W, Hsieh CL. CCR2 deficiency alters activation of microglia subsets in traumatic brain injury. 2021. PMID: 34551293


  2. Anastasiou C, Trupin L, Glidden DV, Li J, Gianfrancesco M, Shiboski S, Schmajuk G, Yazdany J. Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016. 2020. PMID: 32558160


  4. Schmajuk G, Montgomery AD, Leonard S, Li J, Gianfrancesco M, Seet A, Izadi Z, Yazdany J, Keyhani S. Factors Associated With Hospitalization and Death After COVID-19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data. 2021. PMID: 34423917


  5. Li J, Ringold S, Curtis JR, Michaud K, Johansson T, Yun H, Yazdany J, Schmajuk G. Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry. 2021. PMID: 34338816


  6. Izadi Z, Li J, Evans M, Hammam N, Katz P, Ogdie A, Suter LG, Yazdany J, Schmajuk G. Socioeconomic Disparities in Functional Status in a National Sample of Patients With Rheumatoid Arthritis. 2021. PMID: 34347058


  7. Subash M, Liu LH, DeQuattro K, Choden S, Jacobsohn L, Katz P, Bajaj P, Barton JL, Bartels C, Bermas B, Danila MI, Downey C, Ferguson S, Reiter K, Wahl E, Weinstein E, Zell J, Schmajuk G, Yazdany J. The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology. 2021. PMID: 34288595


  9. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J, COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. 2021. PMID: 34049860


  12. Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, O'Dell JR, Schmajuk G, Werth VP, Melles RB, Marmor MF. Collaboration for the Management of Hydroxychloroquine. 2021. PMID: 33752915


  14. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry. 2020. PMID: 33146001


  15. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2021. PMID: 33504483


  16. Hammam N, Evans M, Morgan E, Reimold A, Anastasiou C, Kay JL, Yazdany J, Schmajuk G. Treatment of Sarcoidosis in U.S. Rheumatology Practices: Data from ACR's Rheumatology Informatics System for Effectiveness (RISE) Registry. 2020. PMID: 33105057


  17. Schmajuk G, Li J, Evans M, Anastasiou C, Kay JL, Yazdany J. Quality of care for patients with SLE: data from the American College of Rheumatology's RISE registry. 2020. PMID: 32937019


  18. Izadi Z, Schmajuk G, Gianfrancesco M, Subash M, Evans M, Trupin L, Yazdany J. Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures. 2020. PMID: 32937026


  19. Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger WB, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Aringer M. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. 2020. PMID: 32816709


  20. Gianfrancesco MA, McCulloch CE, Trupin L, Graf J, Schmajuk G, Yazdany J. Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study. 2020. PMID: 32807591


  22. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2020. PMID: 32471903


  23. Zoe Quandt, Laura Trupin, Michael Evans, Gabriela Schmajuk, Mark Stuart Anderson, Jeff A Bluestone, Yazdany Jinoos. SAT-418 Finding the Needles in the Haystack: Harnessing the Electronic Health Record to Find Thyroid Immune Related Adverse Events. 2020. PMID:


  24. Norgeot B, Muenzen K, Peterson TA, Fan X, Glicksberg BS, Schenk G, Rutenberg E, Oskotsky B, Sirota M, Yazdany J, Schmajuk G, Ludwig D, Goldstein T, Butte AJ. Protected Health Information filter (Philter): accurately and securely de-identifying free-text clinical notes. 2020. PMID: 32337372


  25. Liu LH, Garrett SB, Li J, Ragouzeos D, Berrean B, Dohan D, Katz PP, Barton JL, Yazdany J, Schmajuk G. Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis. 2020. PMID: 32270591


  26. Schmajuk G, Li J, Evans M, Anastasiou C, Izadi Z, Kay JL, Hammam N, Yazdany J. RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs. 2020. PMID: 32234243


  28. Bansback N, Curtis JR, Huang J, He Z, Evans M, Johansson T, Michaud K, Schmajuk G, Liao KP. Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices. 2020. PMID: 32043831


  29. French S, Choden S, Schmajuk G. Quality Measures and Quality Improvement Initiatives in Osteoporosis-an Update. 2019. PMID: 31782030


  30. Strait A, Castillo F, Choden S, Li J, Whitaker E, Falasinnu T, Schmajuk G, Yazdany J. Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review. 2019. PMID: 31722023


  31. Schmajuk G, Trupin L, Yelin E, Blanc PD. Prevalence of Arthritis and Rheumatoid Arthritis in Coal Mining Counties of the U.S. 2019. PMID: 30875457


  32. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 2019. PMID: 31385462


  33. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. 2019. PMID: 31383717


  34. Izadi Z, Katz PP, Schmajuk G, Gandrup J, Li J, Gianfrancesco M, Yazdany J. Effects of language, insurance and race/ethnicity on measurement properties of the PROMIS Physical Function Short Form 10a in rheumatoid arthritis. 2018. PMID: 30099861


  36. Ying D, Gianfrancesco MA, Trupin L, Yazdany J, Greidinger E, Schmajuk G. Increased risk of ischemic stroke in systemic sclerosis: a national cohort study of US veterans. 2019. PMID: 30877213


  37. Norgeot B, Glicksberg BS, Trupin L, Lituiev D, Gianfrancesco M, Oskotsky B, Schmajuk G, Yazdany J, Butte AJ. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis. 2019. PMID: 30874779


  38. Patterson S, Schmajuk G, Evans M, Aggarwal I, Izadi Z, Gianfrancesco M, Yazdany J. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. 2019. PMID: 30686706


  40. Patterson SL, Schmajuk G, Jafri K, Yazdany J, Katz P. Obesity Independently Associates with Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus. 2018. PMID: 29740985


  41. Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, Yazdany J, Schmajuk G. Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates. 2018. PMID: 30504507


  42. Yazdany J, Caplan L, Fitzgerald J, Schmajuk G. Editorial: The Evolving Art and Science of American College of Rheumatology Guidelines. 2018. PMID: 30499229


  43. Schmajuk G, Jafri K, Evans M, Shiboski S, Gianfrancesco M, Izadi Z, Patterson SL, Aggarwal I, Sarkar U, Dudley RA, Yazdany J. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. 2018. PMID: 30449650


  44. Schmajuk G, Yazdany J. Further Lessons in Pneumocystis Pneumonia Prophylaxis. 2018. PMID: 30398556


  45. Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. 2018. PMID: 30128552


  46. Ragouzeos D, Gandrup J, Berrean B, Li J, Murphy M, Trupin L, Yazdany J, Schmajuk G. "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. 2018. PMID: 30446358


  47. Schmajuk G, Hoyer BF, Aringer M, Johnson SR, Daikh DI, Dörner T. Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus. 2018. PMID: 29287313


  49. Li J, Yazdany J, Trupin L, Izadi Z, Gianfrancesco M, Goglin S, Schmajuk G. Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study. Volume 6 of Issue 2. 2018. PMID: 29743158


  50. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Dudley RA, Yazdany J. Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 38 of Issue 2. 2018. PMID: 29273937


  52. Murray SG, Yim JWL, Croci R, Rajkomar A, Schmajuk G, Khanna R, Cucina RJ. Using Spatial and Temporal Mapping to Identify Nosocomial Disease Transmission of Clostridium difficile. 2017. PMID: 29059280


  53. Jafri K, Ogdie A, Qasim A, Patterson SL, Gianfrancesco M, Izadi Z, Katz P, Yazdany J, Schmajuk G. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Volume 37 of Issue 2. 2017. PMID: 28993952


  54. Schmajuk G, Yazdany J. Leveraging the electronic health record to improve quality and safety in rheumatology. Volume 37 of Issue 10. 2017. PMID: 28852846


  55. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 37 of Issue 10. 2017. PMID: 28748425


  57. Schmajuk G, Tonner C, Trupin L, Yazdany J. Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis. Volume 69 of Issue 5. 2017. PMID: 27390167


  59. Katz P, Margaretten M, Schmajuk G, Yazdany J, Yelin E. Reply. Volume 69 of Issue 3. 2017. PMID: 28129462


  60. Schmajuk G, Tonner C, Trupin L, Li J, Sarkar U, Ludwig D, Shiboski S, Sirota M, Dudley RA, Murray S, Yazdany J. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab. Volume 96 of Issue 13. 2017. PMID: 28353614


  61. Katz PP, Andrews J, Yazdany J, Schmajuk G, Trupin L, Yelin E. Is frailty a relevant concept in SLE? Volume 4 of Issue 1. 2017. PMID: 28243456


  62. Schmajuk G, Tonner C, Miao Y, Yazdany J, Gannon J, Boscardin WJ, Daikh DI, Steinman MA. Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate. 2016. PMID: 27977768


  63. Yazdany J, Robbins M, Schmajuk G, Desai S, Lacaille D, Neogi T, Singh JA, Genovese M, Myslinski R, Fisk N, Francisco M, Newman E. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Volume 68 of Issue 11. 2016. PMID: 27564778


  64. Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, Lacaille D, Barber CE, Orozco C, Bunyard M, Bergman MJ, Passo M, Matteson EL, Olson R, Silverman S, Warren R, Nola K, Robbins M. Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures. Volume 68 of Issue 10. 2016. PMID: 27390129


  65. Bays A, Wahl E, Daikh DI, Yazdany J, Schmajuk G. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. Volume 16 of Issue a. 2016. PMID: 27527720


  66. J. Andrews, E. Wahl, G. Schmajuk, E. Yelin, P. Katz. THU0096 Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis. 2016. PMID:


  67. Katz PP, Barton J, Trupin L, Schmajuk G, Yazdany J, Ruiz PJ, Yelin E. Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Outcomes in Rheumatoid Arthritis. Volume 68 of Issue 5. 2016. PMID: 26414775


  68. Murray SG, Schmajuk G, Trupin L, Gensler L, Katz PP, Yelin EH, Gansky SA, Yazdany J. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. Volume 11 of Issue 1. 2016. PMID: 26731012


  69. Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis. Volume 68 of Issue 1. 2016. PMID: 25779719


  71. Scheibe MM, Imboden JB, Schmajuk G, Margaretten M, Graf JD, Chen AH, Yelin EH, Yazdany J. Efficiency Gains for Rheumatology Consultation Using a Novel Electronic Referral System in a Safety-Net Health Setting. Volume 67 of Issue 8. 2015. PMID: 25623810


  72. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus. Volume 67 of Issue 8. 2015. PMID: 25623919


  73. Schmajuk G, Tonner C, Yazdany J. Factors associated with access to rheumatologists for Medicare patients. Volume 45 of Issue 4. 2015. PMID: 26319646


  74. N. Leuchten, R. Brinks, A. Hoyer, M. Schoels, M. Aringer, S. Johnson, G. Schmajuk, D. Daikh, T. Dörner, G. Bertsias. SAT0415 Performance of Anti-Nuclear Antibodies (ANA) for Classifying Systemic Lupus Erythematosus (SLE): A Systematic Literature Review and Meta-Regression of Diagnostic Data. 2015. PMID:


  75. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Volume 67 of Issue 5. 2015. PMID: 25331828


  76. Yelin E, Yazdany J, Tonner C, Trupin L, Criswell LA, Katz P, Schmajuk G. Interactions between patients, providers, and health systems and technical quality of care. Volume 67 of Issue 3. 2015. PMID: 25132660


  77. Schmajuk G, Bozic KJ, Yazdany J. Using medicare data to understand health care value--reply. Volume 175 of Issue 3. 2015. PMID: 25730567


  78. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Volume 67 of Issue 1. 2015. PMID: 25049114


  79. Slavotinek A, Kaylor J, Pierce H, Cahr M, DeWard SJ, Schneidman-Duhovny D, Alsadah A, Salem F, Schmajuk G, Mehta L. CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein. 2014. PMID: 25557780


  80. Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Volume 66 of Issue 10. 2014. PMID: 25244314


  81. Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. Volume 174 of Issue 10. 2014. PMID: 25156406


  82. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Volume 66 of Issue 8. 2014. PMID: 24470205


  83. Su R, Schmajuk G. Proteome-wide analysis and CXCL4 in systemic sclerosis. 2014. PMID: 24738678


  84. Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study. Volume 23 of Issue 8. 2014. PMID: 24614054


  85. Schmajuk G, Solomon DH, Yazdany J. Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review. Volume 65 of Issue 12. 2013. PMID: 23926092


  86. Margaretten ME, Katz P, Schmajuk G, Yelin E. Missed opportunities for depression screening in patients with arthritis in the United States. 2013. PMID: 23897128


  88. Stephens C, Sackett N, Pierce R, Schopfer D, Schmajuk G, Moy N, Bachhuber M, Wallhagen MI, Lee SJ. Transitional care challenges of rehospitalized veterans: listening to patients and providers. 2013. PMID: 23560514


  89. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Volume 65 of Issue 3. 2013. PMID: 23436818


  90. Barton JL, Schmajuk G, Trupin L, Graf J, Imboden J, Yelin EH, Schillinger D. Poor knowledge of methotrexate associated with older age and limited English-language proficiency in a diverse rheumatoid arthritis cohort. Volume 15 of Issue 5. 2013. PMID: 24432366


  91. Katz PP, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Barton J, Criswell LA, Yelin EH. Sex differences in assessment of obesity in rheumatoid arthritis. Volume 65 of Issue 1. 2013. PMID: 22833513


  92. Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, Schmajuk G, Julian L, Katz P, Criswell LA, Yelin E. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. Volume 27 of Issue 10. 2012. PMID: 22588825


  93. Gabriela Schmajuk, Michael Lyon. An Overview. 2011. PMID:


  94. Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, Yazdany J. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. Volume 305 of Issue 5. 2011. PMID: 21285425


  95. Gillis JZ, Panopalis P, Schmajuk G, Ramsey-Goldman R, Yazdany J. Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators. Volume 63 of Issue 1. 2011. PMID: 20734353


  96. Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Chakravarty E, Schwarz EB. Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Volume 63 of Issue 3. 2010. PMID: 21080446


  97. Schmajuk G, Yazdany J. Drug monitoring in systemic lupus erythematosus: a systematic review. Volume 40 of Issue 6. 2010. PMID: 21030066


  98. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Volume 62 of Issue 7. 2010. PMID: 20589692


  99. Schmajuk G, Yazdany J, Trupin L, Yelin E. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Volume 62 of Issue 3. 2010. PMID: 20391485


  100. Schmajuk G, Chakravarty EF. Arthritis: in the eye of the beholder? 2009. PMID: 19738206


  101. Sainani KL, Schmajuk G, Liu V. A caution on interpreting odds ratios. 2009. PMID: 19725246


  103. Schmajuk G, Bush TM, Burkham J, Krishnan E, Chung L. Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients. 2009. PMID: 19796557


  104. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, Yelin E. A quality indicator set for systemic lupus erythematosus. Volume 61 of Issue 3. 2009. PMID: 19248127


  105. Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. 2007. PMID: 17665462